Global Hemodialysis and Peritoneal Dialysis Market By Type (Hemodialysis and Peritoneal dialysis), By Product (Device, Consumables, and Services), By End-Use (Home-based and Hospital-based), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: Jul 2022
- Report ID: 53915
- Number of Pages: 323
- Format:
- keyboard_arrow_up
Hemodialysis and Peritoneal Dialysis Market Overview:
The global market for hemodialysis and peritoneal dialysis was worth USD 84,250 million in 2021. It is projected to grow at a CAGR of 7.41% between 2023 and 2032.
The market is driven by several factors, including the rising incidence of Acute Kidney Injury (AKI), a shortage of organ donors, transplant risks, technological advances, and initiatives taken by the top players to introduce new products and services.
The COVID-19 pandemic, which has caused a large demand for dialysis around the globe, is another factor. This has led to increased financial incentives and regulatory support for the market from different government agencies. These factors will contribute to the positive growth in the market over the forecast period.
Global Hemodialysis and Peritoneal Dialysis Market Scope:
Type analysis
The market leader in hemodialysis was the segment with the highest revenue share at over 84.2% in 2021. It is expected that the segment will continue to grow at the CAGR for the forecast period. The hemodialysis market is further divided into short-term hemodialysis (conventional), and nocturnal.
Peritoneal dialysis can be sub-segmented into Ambulatory Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD). This segment is driven by an increasing number of ESRD sufferers, a rise in the geriatric population with kidney disease, and the increasing prevalence of diabetes and high blood pressure.
The World Population Ageing 2020 report estimates that there are 726 million people over 65 in the world. By 2050, the population is expected to increase by more than two-thirds to 1.4 billion people. The segment’s growth is expected to be significantly boosted by an aging population and a rising incidence of CKD.
A hemodialyzer is used to eliminate extra chemicals and fluids from your body. Dialysate is a fluid that comes in contact with blood as it passes through the filter. It is similar to a bodily fluid but without the presence of impurities. This type of dialysis is very complex and requires a strict treatment plan and limited mobility and transport options for patients.
It also involves the establishment and maintenance of vascular access such as a dialysis catheter, or the formation or grafting of an AV fistula in the arm or groin to allow dialysis patients access to the high blood flow required.
Product analysis
The service segment was the dominant market share in 2021 with more than 54.0%. This is due to an increase in dialysis service providers as well as an increase in ESRD prevalence. Several dialysis service providers have opened new centers around the globe to expand their services, which will help boost segment growth.
Market growth will be further boosted by technological advancements and other initiatives taken by different manufacturers. DaVita Care Connect is a secure telehealth system that DaVita integrated into its home dialysis segment in February 2021. It was just one of many connected technologies that DaVita offered to patients who prefer to be treated at home.
Consumables will grow at a 5.8% annual compound rate during the forecast period. The government is expected to make significant investments to improve patient safety, patient-centered healthcare, and efficacy over the forecast period. Advanced materials such as peroxides and iodine are being developed by companies to create catheters. This can increase the catheter’s life expectancy and decrease the likelihood of it malfunctioning.
Antimicrobial-coated catheters are in high demand, which helps to reduce the incidence of bloodstream infections. The growth of the consumable market is also being influenced by new dialyzer manufacturing technologies like improved surface contact and cutoff membrane dialyzers. The consumables market can be further divided into bloodlines, concentrates, and catheters.
End-use analysis
With a market share of more than 81.0%, the hospital-based segment was the dominant segment in 2021. Because of the high quality and experience of hospital staff, the segment will likely continue to lead the market in the future. A professional and experienced team of renal care professionals ensures that patients receive optimal treatment in hospitals and dialysis centers.
The segment will be driven by the increasing focus on independent dialysis centers as well as the adoption of in-center dialysis patients. Companies are also focusing their efforts on developing customized hemodialysis machines that can be used for a wide range of interventions. This will likely have an impact on the user experience.
Home-based segments are expected to grow at a 6.6% CAGR over the forecast period. There are many benefits to home dialysis, such as improved quality of life and lower travel costs. It is also more flexible and can be done at home, making it easier for patients to move around. This will increase its adoption rate over the next few years.
The segment will also benefit from an increase in home dialysis among older people with various renal problems. Patients are increasingly choosing this method of dialysis because it is convenient and easy to use.
Кеу Маrkеt Ѕеgmеntѕ
By Type
- Hemodialysis
- Conventional hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
- Peritoneal dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
By Product
- Device
- Machine
- Dialyzer
- Water treatment system
- Others
- Consumables Bloodline
- Concentrates
- Catheters
- Others
- Services
By End-Use
- Home-based
- Hospital-based
Market Dynamics:
A rising number of APIs will drive demand for hemodialysis as well as peritoneal dialysis. According to the National Kidney Foundation, Inc., more than one-seventh of Americans are affected by kidney disease.
Below is the chart that shows how many Americans aged 18 and older are affected by chronic kidney disease (CKD). It also includes gender-specific information. The CDC estimates that CKD affects more than 37 million people. According to the same source, CKD can cause dialysis and is more common in those over 65.
In addition, dialysis requirements have increased in recent years. According to the National Kidney Foundation, 785,883 Americans suffered from kidney failure in 2018. 554,038 of these people received dialysis. According to the FDA data, approximately 10,000 children in the U.S. are affected by acute AKI. The survival rate for these children is between 38% and 43%. AKI causes a 60% death rate in neonates.
Fluid overload is a common problem in children and neonates who are critically ill, especially after cardiac surgery. These factors will likely drive market growth and the demand for neonatal hemodynamics.
Regional Analysis
North America was the dominant market, with a revenue share of more than 34.0% in 2021. The region’s growth is supported by the presence of key players, large investments made by governments to develop innovative medical devices, as well as a favorable reimbursement situation. There is a growing demand for dialysis due to rising kidney disease rates and chronic kidney diseases (CKD).
Other factors that contribute to market growth include increased healthcare spending, government initiatives, and high disposable income.
Asia Pacific is expected to experience the highest CAGR at 5.6% during the forecast period. Market growth will be supported by rising kidney disease incidences, a growing elderly population, and enhanced product development. According to the IDF, South East Asia has approximately 88 million people living with diabetes. This number is expected to increase to 153 million by 2045.
Other factors that contribute to market growth include rising healthcare spending, increased government initiatives, awareness campaigns about CKD, the availability of technologically enhanced products, and newly-established, state-of-the-art healthcare facilities.
Key Regions and Countries covered іn thе rероrt:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Market Share & Key Players Analysis:
The global Hemodialysis and Peritoneal Dialysis market are fragmented. Major players are involved in product development, strategic partnerships, mergers and acquisitions, and joint ventures to vertically incorporate across the value chain. This reduces operational costs and allows for higher profit margins.
In March 2019, BASF SE joined forces with Landa Labs in order to launch its second stir-in pigment, eXpand. Blue (EH 6001) is sold under the Colors & Effects label. eXpand Blue (EH 6001) can be used for automotive coatings as well as outdoor coating applications.
Organic Dyes and Pigments also acquired Premier Colors, Inc. in December 2020 to expand its business in Providence and serve the customers of the former. Premier Colors, Inc. is a South Carolina-based company that supplies specialty chemicals and Hemodialysis and Peritoneal Dialysis s to the paper, textile, paints and coatings, and leather industries. These are the major players in the global Hemodialysis and Peritoneal Dialysis industry.
Маrkеt Кеу Рlауеrѕ:
- Baxter
- B. Braun Melsungen AG
- Fresenius Medical Care AG
- Medtronic
- Asahi Kasei Medical Co., Ltd.
- Nipro Corp.
- Nikkiso Co., Ltd.
- Cantel Medical
- Other Key Players
For the Hemodialysis and Peritoneal Dialysis Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
Q: What is the size of the Hemodialysis and Peritoneal Dialysis market in 2021?A: The Hemodialysis and Peritoneal Dialysis market size is US$ 84,250 million in 2021.
Q: What is the projected CAGR at which the Hemodialysis and Peritoneal Dialysis market is expected to grow at?A: The Hemodialysis and Peritoneal Dialysis market is expected to grow at a CAGR of 7.41% (2023-2032).
Q: List the segments encompassed in this report on the Hemodialysis and Peritoneal Dialysis market?A: Market.US has segmented the Hemodialysis And Peritoneal Dialysis market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type, market has been segmented into Hemodialysis and Peritoneal dialysis. By Product, market has been segmented into Device, Consumables, and Services. By End User, the market has been further divided into Home-based and Hospital-based.
Q: List the key industry players of the Hemodialysis and Peritoneal Dialysis market?A: Baxter, B. Braun Melsungen AG, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., Nikkiso Co., Ltd., Cantel Medical, Other Key Players engaged in the Hemodialysis and Peritoneal Dialysis market.
Q: Which region is more appealing for vendors employed in the Hemodialysis and Peritoneal Dialysis market?A: North America accounted for the highest revenue share of 34%. Therefore, the Hemodialysis and Peritoneal Dialysis industry in North America is expected to garner significant business opportunities over the forecast period.
Q: Name the key areas of business for Hemodialysis and Peritoneal Dialysis?A: U.S., Canada, U.K., Germany & France, are key areas of operation for Hemodialysis and Peritoneal Dialysis Market.
Q: Which segment accounts for the greatest market share in the Hemodialysis and Peritoneal Dialysis industry?A: With respect to the Hemodialysis and Peritoneal Dialysis industry, vendors can expect to leverage greater prospective business opportunities through the hemodialysis segment, as this area of interest accounts for the largest market share.
Hemodialysis and Peritoneal Dialysis MarketPublished date: Jul 2022add_shopping_cartBuy Now get_appDownload Sample - Hemodialysis
- Baxter International Inc Company Profile
- B. Braun Melsungen AG Company Profile
- Fresenius Medical Care AG
- Medtronic
- Asahi Kasei Medical Co., Ltd.
- Nipro Corp.
- Nikkiso Co., Ltd.
- Cantel Medical
- Other Key Players
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |